AnD,
Send me your name and birthdate to my private email and I can let you know.
Kimber,
DeltaF508 is the most common mutation, 70%. About 50% of all patients with CF will have two copies of deltaF508, so obviously not unusual, but fairly usual.
There is research into a new drug that will help patients with certain types of mutations, but that would involve mutations that end in an X, like G542X.
Certainly DeltaF508 is the most studied mutation, but as of now it is still a matter of waiting for a cure or better treatments.
Steve